4//SEC Filing
Gibson Christopher 4
Accession 0001856369-25-000016
CIK 0001601830other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 7:20 PM ET
Size
23.1 KB
Accession
0001856369-25-000016
Insider Transaction Report
Form 4
Gibson Christopher
Director
Transactions
- Conversion
Class A Common Stock
2025-12-04+60,000→ 973,839 total - Sale
Class A Common Stock
2025-12-04$4.63/sh−40,000$185,200→ 933,839 total - Gift
Class A Common Stock
2025-12-04−20,000→ 913,839 total - Conversion
Class B Common Stock
2025-12-04−60,000→ 4,763,334 totalExercise: $0.00→ Class A Common Stock (60,000 underlying)
Holdings
- 386,000(indirect: By LLC)
Class B Common Stock
Exercise: $0.00→ Class A Common Stock (0 underlying) - 388,000(indirect: By LLC)
Class B Common Stock
Exercise: $0.00→ Class A Common Stock (0 underlying) - 50,000(indirect: By Trust)
Class B Common Stock
Exercise: $0.00→ Class A Common Stock (0 underlying) - 666,898
Stock Option (Right to Buy)
Exercise: $10.09Exp: 2034-02-09→ Class A Common Stock (0 underlying) - 1,050,567
Stock Option (Right to Buy)
Exercise: $7.25Exp: 2035-02-03→ Class A Common Stock (0 underlying) - 813,600
Stock Option (Right to Buy)
Exercise: $8.55Exp: 2033-02-01→ Class A Common Stock (0 underlying) - 399,002
Stock Option (Right to Buy)
Exercise: $11.40Exp: 2032-02-04→ Class A Common Stock (0 underlying) - 5,436
Stock Option (Right to Buy)
Exercise: $11.40From: 2022-02-04Exp: 2032-02-04→ Class A Common Stock (0 underlying) - 282,500
Stock Option (Right to Buy)
Exercise: $2.48Exp: 2030-12-30→ Class A Common Stock (0 underlying)
Footnotes (10)
- [F1]Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
- [F10]The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
- [F2]This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.
- [F3]The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
- [F4]The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
- [F5]The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
- [F6]The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- [F7]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- [F8]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- [F9]The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
Documents
Issuer
RECURSION PHARMACEUTICALS, INC.
CIK 0001601830
Entity typeother
Related Parties
1- filerCIK 0001856369
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 7:20 PM ET
- Size
- 23.1 KB